Dishman Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dishman Pharma Quarterly Results    (DHPH)

Here are the latest quarterly results of Dishman Pharma. For more details, see the Dishman Pharma financial fact sheet and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dishman Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,0053,8123,8874,2213,7544,3663,6215,342 
Other income Rs m417617130707715538 
Turnover Rs m4,0473,8883,9044,3513,8244,4423,7765,380 
Expenses Rs m2,9612,8972,7873,1752,7323,2082,6643,875 
Gross profit Rs m1,0449151,1001,0461,0221,1589531,462 
Depreciation Rs m259261271299285309293570 
Interest Rs m319236185205225189134101 
Profit before tax Rs m507494661672583736682829 
Tax Rs m130129191174127190175401 
Profit after tax Rs m378365469498455547507428 
Gross profit margin %26.124.028.324.827.226.526.327.4 
Effective tax rate %25.626.129.025.821.925.825.748.4 
Net profit margin %9.49.612.111.812.112.514.08.0 
Diluted EPS Rs 2.3 2.3 2.9 3.1 2.8 3.4 3.1 2.7  
Diluted EPS (TTM) Rs 8.3 8.5 9.9 10.6 11.1 12.2 12.4 12.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare DISHMAN PHARMA With:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare DISHMAN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Views on news

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - TTK HEALTHCARE COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS